Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Hitgen discloses new IL1-7RA antagonists

March 10, 2021

Xentria submits IND application to the FDA for XTMAB-16 as treatment of sarcoidosis

March 4, 2021

Intrommune Therapeutics initiates phase I study of INT-301 in adults with peanut allergy

March 1, 2021

Amgen discovers new KIF18A inhibitors

Feb. 26, 2021

Neutralizing activity of tozinameran-elicited serum against the B.1.351 lineage of SARS-CoV-2

Feb. 23, 2021

Opioid vaccines elicit antibodies against carfentanil and fentanyl

Feb. 23, 2021

European Commission approves Heplisav B

Feb. 22, 2021

Valneva initiates further phase III study of chikungunya vaccine candidate VLA-1553

Feb. 22, 2021

GSK initiates phase III program with RSV vaccine candidate GSK-3844766A for older adults

Feb. 18, 2021

WHO lists two versions of AstraZeneca/Oxford COVID-19 vaccine for emergency use

Feb. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...